相关实验视频
Updated: May 26, 2025

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
热尼斯通过抑制雄激素受体通路来抵抗割抵抗性前列腺癌
Xiao-Ping Yu1, Lu-Jie Zheng2, Jia-Li Yan2
1School of Medicine and Nursing, Chengdu University, Chengdu 610106, China.
一种大豆化合物基尼斯因通过阻断雄激素合成和破坏割抵抗性前列腺癌 (CRPC) 细胞中的雄激素受体信号传递,有效地抑制前列腺癌的生长.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 前列腺癌是一种常见的恶性瘤,通常在晚期被诊断出来.
- 抗割前列腺癌 (CRPC) 是一个严重的治疗挑战,预后不佳.
- 基因斯坦是一种来自大豆的异黄,具有潜在的抗瘤特性.
研究的目的:
- 调查基因斯坦影响割抵抗性前列腺癌 (CRPC) 的分子机制.
- 评估基因斯坦对CRPC中雄激素合成和雄激素受体 (AR) 信号通路的影响.
主要方法:
- 这项研究检查了基尼斯坦对安德روج因新生代合成途径中的关键酶的影响.
- 在CRPC细胞中评估了Genistein对雄激素受体 (AR) 激活和核转位的影响.
主要成果:
- 热尼斯坦显著降低了AKR1C3,SRD5A2,CYP11A1和3βHSD的表达,这些酶对雄激素合成至关重要.
- 基因斯坦治疗抑制了雄激素受体 (AR) 的激活和核转位.
结论:
- 热尼斯通过抑制雄激素合成和AR信号传递来表现出对CRPC的双重作用机制.
- 这些发现支持了基因斯坦作为治疗治疗割抵抗性前列腺癌的治疗剂的潜力.
更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
06:44Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
Published on: September 8, 2017
相关概念视频
Mitogens and the Cell Cycle
Internal Receptors
Targeted Cancer Therapies
There are several types of targeted therapies against...
Inhibition of Cdk Activity
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...